82.1 F
Charlotte Amalie
Thursday, August 11, 2022
HomeNewsMilitaryV.I. Participates in Federal Law Enforcement Training on Prescription Drugs, Fentanyl

V.I. Participates in Federal Law Enforcement Training on Prescription Drugs, Fentanyl

Gretchen C. F. Shappert, United States Attorney for the USVI (File photo)
Gretchen C. F. Shappert, United States Attorney for the USVI (File photo)

The High Intensity Drug Trafficking Area (HIDTA) Program, in partnership with the Drug Enforcement Administration (DEA) and the Virgin Islands National Guard (VING) Counterdrug Unit, sponsored a half-day of training recently on prescription drug and Fentanyl abuse, according to a press release from U.S. Attorney Gretchen C.F. Shappert.

Over 40 law enforcement officers from 12 different local and federal law enforcement agencies participated in the training. The day’s training identified not only the hazards to the first responder community of being exposed to Fentanyl but resources available locally to support law enforcement, as well as potential gaps in traditional protective services for first responders. Instructors from the Caribbean Region DEA Tactical Diversion Squad highlighted the problems with diversion of prescription drugs and the hazards of Fentanyl abuse.

Throughout the United States, Fentanyl is becoming a major issue for law enforcement because it is highly toxic and hazardous. Fentanyl is a synthetic opioid that is 80-100 times stronger than morphine. Pharmaceutical fentanyl was developed for pain management treatment of cancer patients, applied in a patch on the skin. Because of its powerful opioid properties, it is also diverted for abuse and has been associated with numerous drug overdose deaths.

Fentanyl is oftentimes added to heroin to increase its potency, or it can be promoted by illicit drug dealers as highly potent heroin. Many users believe that they are purchasing heroin and actually don’t know that they are purchasing fentanyl – which often results in overdose deaths. Clandestinely-produced fentanyl is primarily manufactured in Mexico.

Advertising (skip)
Advertising (skip)
Advertising (skip)

“Fentanyl abuse and prescription drug abuse are growing problems in the Caribbean region,” Shappert said. “We are grateful that our law enforcement partners in the U.S.V.I. are taking the initiative to get out in front of the problem.”

For more information on Fentanyl and prescription drug abuse, visit the DEA website.

Print Friendly, PDF & Email
Keeping our community informed is our top priority.
If you have a news tip to share, please call or text us at 340-228-8784.




Support local + independent journalism in the U.S. Virgin Islands

Unlike many news organizations, we haven't put up a paywall – we want to keep our journalism as accessible as we can. Our independent journalism costs time, money and hard work to keep you informed, but we do it because we believe that it matters. We know that informed communities are empowered ones. If you appreciate our reporting and want to help make our future more secure, please consider donating.

FROM FACEBOOK

Comments Box SVG iconsUsed for the like, share, comment, and reaction icons
Load more
Gretchen C. F. Shappert, United States Attorney for the USVI (File photo)
Gretchen C. F. Shappert, United States Attorney for the USVI (File photo)
The High Intensity Drug Trafficking Area (HIDTA) Program, in partnership with the Drug Enforcement Administration (DEA) and the Virgin Islands National Guard (VING) Counterdrug Unit, sponsored a half-day of training recently on prescription drug and Fentanyl abuse, according to a press release from U.S. Attorney Gretchen C.F. Shappert. Over 40 law enforcement officers from 12 different local and federal law enforcement agencies participated in the training. The day’s training identified not only the hazards to the first responder community of being exposed to Fentanyl but resources available locally to support law enforcement, as well as potential gaps in traditional protective services for first responders. Instructors from the Caribbean Region DEA Tactical Diversion Squad highlighted the problems with diversion of prescription drugs and the hazards of Fentanyl abuse. Throughout the United States, Fentanyl is becoming a major issue for law enforcement because it is highly toxic and hazardous. Fentanyl is a synthetic opioid that is 80-100 times stronger than morphine. Pharmaceutical fentanyl was developed for pain management treatment of cancer patients, applied in a patch on the skin. Because of its powerful opioid properties, it is also diverted for abuse and has been associated with numerous drug overdose deaths. Fentanyl is oftentimes added to heroin to increase its potency, or it can be promoted by illicit drug dealers as highly potent heroin. Many users believe that they are purchasing heroin and actually don’t know that they are purchasing fentanyl – which often results in overdose deaths. Clandestinely-produced fentanyl is primarily manufactured in Mexico. “Fentanyl abuse and prescription drug abuse are growing problems in the Caribbean region,” Shappert said. “We are grateful that our law enforcement partners in the U.S.V.I. are taking the initiative to get out in front of the problem.” For more information on Fentanyl and prescription drug abuse, visit the DEA website.